drugset / Trial / NCT00365248

TachoSil Paediatric Liver Trial (TC-019-IN)

NCT00365248

Phase 3 Completed 16 enrolled Nycomed
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The overall objective is to assess the haemostatic efficacy and safety of TachoSil for control of local bleeding in paediatric patients undergoing surgical resection of the liver with our without segmental liver transplantation.

Timeline

Start
2005-10
Primary completion
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic

Indications